Confirmation that somatic mutations of beta‐2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial

AIMS: Beta2‐microglobulin (B2M) forms part of the HLA class I complex and plays a role in metastatic biology. B2M mutations occur frequently in mismatch repair‐deficient colorectal cancer (dMMR CRC), with limited data suggesting they may protect against recurrence. Our experimental study tested this...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrow, Paul, Richman, Susan D, Wallace, Andrew J, Handley, Kelly, Hutchins, Gordon G A, Kerr, David, Magill, Laura, Evans, D Gareth, Gray, Richard, Quirke, Phil, Hill, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772160/
https://www.ncbi.nlm.nih.gov/pubmed/31062389
http://dx.doi.org/10.1111/his.13895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772160/
https://www.ncbi.nlm.nih.gov/pubmed/31062389
http://dx.doi.org/10.1111/his.13895

Ejemplares similares